Cargando…
Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications
Soft tissue sarcomas of childhood are a group of heterogeneous tumors thought to be derived from mesenchymal stem cells. Surgical resection is effective only in about 50% of cases and resistance to conventional chemotherapy is often responsible for treatment failure. Therefore, investigations on nov...
Autores principales: | Ciarapica, Roberta, Miele, Lucio, Giordano, Antonio, Locatelli, Franco, Rota, Rossella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3126730/ https://www.ncbi.nlm.nih.gov/pubmed/21609503 http://dx.doi.org/10.1186/1741-7015-9-63 |
Ejemplares similares
-
Notch signaling in pediatric soft tissue sarcomas
por: Rota, Rossella, et al.
Publicado: (2012) -
MicroRNAs in rhabdomyosarcoma: pathogenetic implications and translational potentiality
por: Rota, Rossella, et al.
Publicado: (2011) -
Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis
por: Zhang, Qi, et al.
Publicado: (2017) -
Expression of Enhancer of Zeste Homolog 2 (EZH2) Gene in Acute Myeloid Leukemia
por: Hamed, Nahla A. M., et al.
Publicado: (2023) -
Enhancer of Zeste Homolog 2 (EZH2) Mediates Glucolipotoxicity-Induced Apoptosis in β-Cells
por: Dahlby, Tina, et al.
Publicado: (2020)